Schimmelpennink Evert B.
LENZ Therapeutics, Inc. · President
Schimmelpennink Evert B. is listed in public filings as director, officer: President, CEO and Secretary. This Schimmelpennink Evert B. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include LENZ Therapeutics, Inc. (LENZ), iBio, Inc. (IBIO), and Contineum Therapeutics, Inc. Class A Common Stock (CTNM). Investors use Schimmelpennink Evert B.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $692k77.3k shares | BuyMar 27, 2026 | $251.4K28.1k shares | $8.95 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $5.7M358.1k shares | Grant / ExerciseJan 2, 2026 | $5.7M358.1k shares | $16.00 | -- | |
| $14k13.5k shares | Grant / ExerciseNov 20, 2025 | $13.5K13.5k shares | $1.00 | -- | |
| $59k14.8k shares | Grant / ExerciseJun 26, 2025 | $59.1K14.8k shares | $4.01 | -- | |
| $51k49.2k shares | Grant / ExerciseMar 7, 2025 | $4.4K4.2k shares | $1.04 | -- | |
| $7.4M279.1k shares | Grant / ExerciseJan 9, 2025 | $7.4M279.1k shares | $26.34 | -- | |
| $46k18.9k shares | Grant / ExerciseNov 21, 2024 | $46.3K18.9k shares | $2.45 | -- | |
| $47k45k shares | Grant / ExerciseJul 22, 2024 | $46.8K45k shares | $1.04 | -- |